• レポートコード:TPM-2JN065 • 出版社/出版日:Transparency Market Research / 2019年11月28日 • レポート形態:英文、PDF、184ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥857,660 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,301,660 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは羊膜の世界市場について調査・分析し、序論、仮定・研究方法、エグゼクティブサマリー、市場動向、キーインサイト、製品別分析、用途別分析、エンドユーザー別分析、地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、次の構成でお届けいたします。 ・序論 ・仮定・研究方法 ・エグゼクティブサマリー ・市場動向 ・キーインサイト ・羊膜の世界市場:製品別 ・羊膜の世界市場:用途別 ・羊膜の世界市場:エンドユーザー別 ・羊膜の世界市場:地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ) ・羊膜の北米市場分析・予測 ・羊膜の欧州市場分析・予測 ・羊膜のアジア太平洋市場分析・予測 ・羊膜の中南米市場分析・予測 ・羊膜の中東・アフリカ市場分析・予測 ・競争状況 |
Chronic burn wounds lead to trauma amongst patients. What adds to the patient’s difficulty is the risk of infection, sepsis, joint problems, and scarring during the management of third-degree burns. Hence, healthcare industries are increasing awareness about amniotic membranes (AM), since these membranes have gained the approval of many health commissions across various countries.
Healthcare providers in the amniotic membrane market are increasingly using fresh amniotic membranes as dressings on burn areas. It has been found that, serology and virology tests validate the use of frozen amnion membrane dressings to minimize the risks of infection transfer. Companies in the amniotic membrane market are increasing the availability of amnion membranes to facilitate the reepithelization of burn wounds. Incremental opportunities related to burn wounds are likely to grow, since the overall surgical wounds domain accounts for the highest revenue amongst all applications in the amniotic membrane market, with a predicted value of ~US$ 1.2 billion by 2027.
The growing trend of amniotic membranes enriched with stem cells is gaining traction in the healthcare landscape. This trend is anticipated to grow even further, since it has been found that, amniotic membrane dressings significantly reduce pain in burn patients.
There is growing demand for human amniotic membranes (hAM) for cardiac tissue regeneration. Hence, healthcare companies in the amniotic membrane market fostering innovation in human-induced pluripotent stem cell (hiPSC)-derived cardiac muscle cells for successful cardiac tissue regeneration. This technique is pervasively becoming a treatment alternative to gelatin-based 3D matrix matrigel protein.
Heart attacks can lead to necrosis of the cardiac tissue. This trend has become a driver for the amniotic membrane market, since increasing rates of heart failures have led to several deaths, worldwide. Individuals are becoming increasingly aware about hAM. Hence, companies in the amniotic membrane market are increasing the availability of hAM in hospitals and ambulatory surgical centers to aid successful regeneration of injured cardiac tissue.
Healthcare companies are focusing on innovation regarding the combination of stem cells and synthetic materials for cardiac tissue regeneration. Decellularized biological matrices are also emerging as a useful alternative for tissue regeneration.
Foot pain is one of the most common orthopedic complaints in the healthcare landscape. To cater to this prevalent health condition, healthcare industries are developing improved amniotic allografts to reduce joint and soft tissue pain. The introduction of amniotic allografts has helped reduce pain and enhance healing in patients suffering from foot and ankle pain.
Growing incidence of repeated trauma and joint pain in the feet has triggered the demand for amniotic allografts. Healthcare providers are providing relief to patients after several clinical trials through musculoskeletal ultrasound, electromyography and computerized tomography scans. Amniotic allografts are becoming increasingly popular amongst patients, since this technique provides long-term relief, unlike the conventional non-operative management of joint pain.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Amniotic Membrane Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Amniotic Membrane Market Analysis and Forecast, 2017–2027
5. Key Insights
5.1. Clinical Trial Analysis
5.2. Regulatory Scenario of Amniotic Membrane Products
5.3. Reimbursement Scenario of Amniotic Membrane
6. Global Amniotic Membrane Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
6.3.1. Cryopreserved Amniotic Membrane
6.3.2. Lyophilization Amniotic Membrane
6.4. Global Amniotic Membrane Market Attractiveness, by Product
7. Global Amniotic Membrane Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Amniotic Membrane Market Value (US$) Forecast, by Application, 2017–2027
7.3.1. Surgical Wounds
7.3.2. Ophthalmology
7.3.3. Others
7.4. Global Amniotic Membrane Market Attractiveness, by Application
8. Global Amniotic Membrane Market Analysis and Forecasts, by End User
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Specialized Clinics
8.3.4. Research Centers & Laboratories
8.4. Global Amniotic Membrane Market Attractiveness, by End User
9. Global Amniotic Membrane Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Amniotic Membrane Market Attractiveness, by Region
10. North America Amniotic Membrane Market Analysis and Forecast
10.1. Introduction
10.2. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
10.2.1. Cryopreserved Amniotic Membrane
10.2.2. Lyophilization Amniotic Membrane
10.3. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
10.3.1. Surgical Wounds
10.3.2. Ophthalmology
10.3.3. Others
10.4. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Specialized Clinics
10.4.4. Research Centers & Laboratories
10.5. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Amniotic Membrane Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End User
10.6.4. By Country
11. Europe Amniotic Membrane Market Analysis and Forecast
11.1. Introduction
11.2. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
11.2.1. Cryopreserved Amniotic Membrane
11.2.2. Lyophilization Amniotic Membrane
11.3. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
11.3.1. Surgical Wounds
11.3.2. Ophthalmology
11.3.3. Others
11.4. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Specialized Clinics
11.4.4. Research Centers & Laboratories
11.5. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Amniotic Membrane Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End User
11.6.4. By Country/Sub-region
12. Asia Pacific Amniotic Membrane Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
12.2.1. Cryopreserved Amniotic Membrane
12.2.2. Lyophilization Amniotic Membrane
12.3. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
12.3.1. Surgical Wounds
12.3.2. Ophthalmology
12.3.3. Others
12.4. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Specialized Clinics
12.4.4. Research Centers & Laboratories
12.5. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Amniotic Membrane Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End User
12.6.4. By Country/Sub-region
13. Latin America Amniotic Membrane Market Analysis and Forecast
13.1. Introduction
13.2. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
13.2.1. Cryopreserved Amniotic Membrane
13.2.2. Lyophilization Amniotic Membrane
13.3. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
13.3.1. Surgical Wounds
13.3.2. Ophthalmology
13.3.3. Others
13.4. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Specialized Clinics
13.4.4. Research Centers & Laboratories
13.5. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Amniotic Membrane Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End User
13.6.4. By Country/Sub-region
14. Middle East & Africa Amniotic Membrane Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
14.2.1. Cryopreserved Amniotic Membrane
14.2.2. Lyophilization Amniotic Membrane
14.3. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
14.3.1. Surgical Wounds
14.3.2. Ophthalmology
14.3.3. Others
14.4. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Specialized Clinics
14.4.4. Research Centers & Laboratories
14.5. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6. Middle East & Africa Amniotic Membrane Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End User
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Share Analysis, by Company, 2018
15.2. Company Profiles
15.2.1. Integra LifeSciences
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Company Financials
15.2.1.3. Growth Strategies
15.2.1.4. SWOT Analysis
15.2.2. MiMedx
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Company Financials
15.2.2.3. Growth Strategies
15.2.2.4. SWOT Analysis
15.2.3. Skye Biologics, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Growth Strategies
15.2.3.3. SWOT Analysis
15.2.4. Katena Products, Inc.
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Growth Strategies
15.2.4.3. SWOT Analysis
15.2.5. Amnio Technology, LLC
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Growth Strategies
15.2.5.3. SWOT Analysis
15.2.6. Applied Biologics
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Growth Strategies
15.2.6.3. SWOT Analysis
15.2.7. TissueTech, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Growth Strategies
15.2.7.3. SWOT Analysis
15.2.8. Stryker
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Company Financials
15.2.8.3. Growth Strategies
15.2.8.4. SWOT Analysis
15.2.9. Osiris Therapeutics, Inc.
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Company Financials
15.2.9.3. Growth Strategies
15.2.9.4. SWOT Analysis
15.2.10. Human Regenerative Technologies, LLC
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Growth Strategies
15.2.10.3. SWOT Analysis
List of TablesTable 01: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 03: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 04: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 05: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 06: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 07: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 08: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 09: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 10: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 11: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 12: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 14: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 15: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 16: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 17: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 18: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 19: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 20: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 22: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 23: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 24: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027